Outpatient Oncology Infusion Market Size

Outpatient Oncology Infusion Market Size

Outpatient Oncology Infusion Market size surpassed USD 63.6 billion in 2021 and is expected to witness 11% CAGR from 2022 to 2030 owing to the rapid increase in product demand and the increase in medical costs around the world. Surging technological advancements in infusion pumps along with growing safety concern associated with the cancer therapy will accelerate the business growth.

To get key market trends

  Download Free Sample

In addition, continuous improvement in cancer infusion therapy, availability of skilled nursing staff, professional training, and transparency regarding quality of care are expected to drive industry growth. In addition, rapid technological advances in intravenous devices, along with the government's favorable policies for the elderly, have boosted the demand for outpatient oncology infusion therapy devices.

The COVID-19 pandemic had a moderate impact on the outpatient oncology infusion market. In the midst of a pandemic, identifying new cancer cases around the world is declining and lagging. In addition, cancer patients have reported delays in cancer treatment, including clinic follow-up appointments and cancer therapies, such as infusion therapies, surgical tumor removal and radiation therapy. However, as the restrictions got removed in 2021, treatment for breast, urinary and gynecologic tumors increased (between 3% and 73%).

The outpatient oncology infusion centers offer a variety of treatments such as chemotherapy, blood transfusions, platelet transfusions, IV antibiotics, and hydration and electrolyte replacement. It also provides long-term and short infusion therapy to patients in an appropriate manner. Outpatient oncology infusion therapy delivers medications intravenously.